Evidence map›Paper›PMID 38472357›Full record

ArticleCellular & molecular immunology2024

Neutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS.

Changchang Xu, Lin Zhang, Shaoyu Xu, Zichen Wang, Qi Han, Ying Lv, Xingfang Wang, Xiangxin Zhang, Qingju Zhang, Ying Zhang and 9 more

Open access · greenAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Changchang Xu *Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Lin Zhang *Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Shaoyu XuDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Zichen WangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Qi HanDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Ying LvDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Xingfang WangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Xiangxin ZhangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Qingju ZhangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Ying ZhangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Simeng HeDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Qiuhuan YuanDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Yuan BianDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Chuanbao LiDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Jiali WangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Feng XuDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Yihai CaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.ORCID 0000-0003-1308-0065
Jiaojiao PangDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China. jiaojiaopang@email.sdu.edu.cn.
Yuguo ChenDepartment of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China. chen919085@sdu.edu.cn.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNKarolinska Institutet · SEShandong University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82030059National Natural Science Foundation of China (National Science Foundation of China) 82172127
6 · The paper itself

Abstract

Acetaldehyde dehydrogenase 2 (ALDH2) mutations are commonly found in a subgroup of the Asian population. However, the role of ALDH2 in septic acute respiratory distress syndrome (ARDS) remains unknown. Here, we showed that human subjects carrying the ALDH2

Indexed as

Aldehyde Dehydrogenase, MitochondrialExtracellular TrapsMice, KnockoutNeutrophilsRespiratory Distress SyndromeSepsisAnimalsDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred C57BLMutationPeroxidaseProtein-Arginine Deiminase Type 4Aldehyde Dehydrogenase, MitochondrialALDH2 protein, humanALDH2 protein, mousePeroxidaseProtein-Arginine Deiminase Type 4ALDH2ARDSNETosisSepsis

Identifiers

PMID38472357
PMCPMC11061144
OpenAlexW4392717599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.